3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Interventions
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Radiotherapy
3
Nivolumab
3
Cetuximab
3
fluoromisonidazole
2
durvalumab
2
Neoadjuvant Therapy
2
Metformin
2
Immunohistochemistry
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Cisplatin
2
sitravatinib
1
ruxolitinib
1
ribociclib
1
fluciclovine F-18
1
dornase alfa
1
avelumab
1
antitumor A
1
alovudine
1
Varenicline
1
Valproic Acid
1
VTX-2337
1
TAK-981
1
Surgical Procedures, Operative
1
Raltegravir Potassium
1
Radiotherapy, Intensity-Modulated
1
Plastic Surgery Procedures
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Squamous Cell Carcinoma of Head and Neck
×
sitravatinib
×
Clear all
NCT03575598
2023-07-27
SNOW
University Health Network, Toronto
Phase EARLY_PHASE1
Completed
10 enrolled